Company profile

Future of Ecolab

#
Rank
136
| Quantumrun Global 1000

Ecolab Inc. is a US worldwide provider of hygiene, water, and energy technologies, and services to the energy, healthcare, hospitality, food and industrial markets. It was established in 1923 as Economics Laboratory by Merritt J. Osborn and renamed "Ecolab" in 1986.

Home Country:
Sector:
Industry:
Chemicals
Website:
Founded:
1923
Global employee count:
47565
Domestic employee count:
21715
Number of domestic locations:
17

Financial Health

Revenue:
$13152800000 USD
3y average revenue:
$13659466667 USD
Operating expenses:
$4299400000 USD
3y average expenses:
$4407500000 USD
Funds in reserve:
$92800000 USD
Market country
Revenue from country
0.53
Revenue from country
0.18
Revenue from country
0.13

Asset Performance

  1. Product/Service/Dept. name
    Global industrial
    Product/Service revenue
    4857800000
  2. Product/Service/Dept. name
    Global institutional
    Product/Service revenue
    4393200000
  3. Product/Service/Dept. name
    Global energy
    Product/Service revenue
    3823700000

Innovation assets and Pipeline

Investment into R&D:
$189000000 USD
Total patents held:
1489
Number of patents field last year:
31

All company data collected from its 2016 annual report and other public sources. The accuracy of this data and the conclusions derived from them depend on this publicly accessible data. If a data point listed above is discovered to be inaccurate, Quantumrun will make the necessary corrections to this live page. 

DISRUPTION VULNERABILITY

Belonging to the chemicals sector means this company will be affected directly and indirectly by a number of disruptive opportunities and challenges over the coming decades. While described in detail within Quantumrun’s special reports, these disruptive trends can be summarized along the following broad points:

*First off, artificial intelligence (AI) systems will discover new thousands of new compounds faster than humans that can, compounds that can be applied to everything from creating new makeup to cleaning agents to more effective medicines.
*This automated process of chemical compound discovery will accelerate once AI systems are integrated with mature quantum computers by the late 2020s, allowing these AI systems will compute ever more massive amounts of data.
*As the Silent and Boomer generations enter deep into their senior years by the late 2020s, this combined demographic (30-40 per cent of the global population) will represent a significant financial strain on the health systems of developed nations. This crisis will encourage these nations to fast-track the testing and approval process for new drugs that may improve the overall physical and mental health of patients so that they can lead more independent lives outside of the health care system. The chemical industry will partner with the pharmaceutical industry to address this market need.

COMPANY’S FUTURE PROSPECTS

Company Headlines